Fungemia by Cryptococcus neoformans in a child with T-Cell Lymphoblastic Lymphoma. Review and case report

Main Article Content

Joanna Acebo Arcentales
Katherine Estefania Mariño Brito
Johana Elizabeth Salgado Apunte

Abstract

Introduction: Cryptococcus neoformans (C. neoformans) is an opportunistic encapsulated yeast that causes infections primarily in immunocompromised patients but, is rare in children. Case: Pediatric patient with T-cell lymphoblastic lymphoma who developed fungemia due to C. neoformans with cutaneous origin. Evolution: The patient evolved favorably, he remained in the Pediatric Intensive Care Unit (PICU) for 18 days and was discharged from the hospital 30 days later in adequate general condition. Conclusion: Cryptococcosis is a rare disease that requires certain associated factors for its establishment, such as the use of corticosteroids, immunodeficiency, chemotherapy, transplantation, etc. It is associated with significant morbidity and mortality, which is why we must consider it in patients like ours with underlying hemato-oncological disease and immunosuppression.

Downloads

Download data is not yet available.

Article Details

How to Cite
Acebo Arcentales, J., Mariño Brito, K. E., & Salgado Apunte, J. E. (2024). Fungemia by Cryptococcus neoformans in a child with T-Cell Lymphoblastic Lymphoma. Review and case report. Revista Ecuatoriana De Pediatría, 25(2), 70-75. https://doi.org/10.52011/RevSepEc/e253
Section
Clinical Case
Author Biographies

Joanna Acebo Arcentales, Hospital Oncológico SOLCA Núcleo de Quito - Hospital Metropolitano

Hospital Oncológico SOLCA Núcleo de Quito; Hospital Metropolitano; Quito, Ecuador

Katherine Estefania Mariño Brito, Hospital Oncológico SOLCA Núcleo de Quito

Hospital Oncológico SOLCA Núcleo de Quito; Quito, Ecuador.

Johana Elizabeth Salgado Apunte, Hospital Oncológico SOLCA Núcleo de Quito

Hospital Oncológico SOLCA Núcleo de Quito; Quito, Ecuador

References

Bonifaz A. Micología Médica Básica. México, D.F.: McGraw Hill; 2012.

Arenas R. Micología Médica Ilustrada. Quinta. México, D.F.: McGraw Hill; 2014.

Murray P, Rosenthal K, Pfaller M. Medical Microbiology. Eight. Canada: Elsevier; 2016.

Maziarz EK, Perfect J. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179–206.

Srikanta D, Santiago-Tirado FH, Doering TL. Cryptococcus neoformans: Historical curiosity to modern pathogen. Yeast. 2014;31(2):47–60.

Casadevall A, Coelho C, Alanio A. Mechanisms of Cryptococcus neoformans-mediated host damage. Front Immunol. 2018;9(APR):1–8.

Voelz K, May RC. Cryptococcal interactions with the host immune system. Eukaryot Cell. 2010;9(6):835–46.

Rohatgi S, Pirofski L anne. Host immunity to Cryptococcus neoformans Soma. Physiol Behav. 2017;176(3):139–48.

Gibson JF, Johnston SA. Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis. Fungal Genet Biol. 2015;78:76–86.

Mukaremera L, Nielsen K. Adaptive immunity to cryptococcus neoformans infections. J Fungi. 2017;3(4):1–20.

Elsegeiny W, Marr KA, Williamson PR. Immunology of cryptococcal infections: Developing a rational approach to patient therapy. Front Immunol. 2018;9(APR).

Velagapudi R, Hsueh YP, Geunes-Boyer S, Wright JR, Heitman J. Spores as infectious propagules of Cryptococcus neoformans. Infect Immun. 2009;77(10):4345–55.

Lizarazo J, Escandón P, Agudelo CI, Castañeda E. Cryptococcosis in Colombian children and literature review. Mem Inst Oswaldo Cruz. 2014;109(6):797–804.

Grimshaw A, Palasanthiran P, Huynh J, Marais B, Chen S, McMullan B. Cryptococcal infections in children: Retrospective study and review from Australia. Future Microbiol. 2019;14(18):1531–44.

Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kusuhara M, Ihn H. Cutaneous cryptococcosis. Med Mycol J. 2019;60(4):101–7.